Burning Rock Biotech (BNR) Equity Ratio (2021 - 2023)

Burning Rock Biotech has reported Equity Ratio over the past 3 years, most recently at 0.74 for Q4 2023.

  • Quarterly results put Equity Ratio at 0.74 for Q4 2023, up 1.26% from a year ago — trailing twelve months through Dec 2023 was 0.74 (up 1.26% YoY), and the annual figure for FY2023 was 0.74, up 1.26%.
  • Equity Ratio for Q4 2023 was 0.74 at Burning Rock Biotech, up from 0.73 in the prior quarter.
  • Over the last five years, Equity Ratio for BNR hit a ceiling of 0.81 in Q4 2021 and a floor of 0.73 in Q4 2022.
  • Median Equity Ratio over the past 3 years was 0.74 (2023), compared with a mean of 0.76.
  • Biggest five-year swings in Equity Ratio: dropped 9.9% in 2022 and later grew 1.26% in 2023.
  • Burning Rock Biotech's Equity Ratio stood at 0.81 in 2021, then dropped by 9.9% to 0.73 in 2022, then grew by 1.26% to 0.74 in 2023.
  • The last three reported values for Equity Ratio were 0.74 (Q4 2023), 0.73 (Q4 2022), and 0.81 (Q4 2021) per Business Quant data.